Cerebain Biotech Corp. (CBBT) Financial Statements (2024 and earlier)

Company Profile

Business Address 600 ANTON BLVD.
COSTA MESA, CA 92626
State of Incorp. NV
Fiscal Year End June 30
Industry (SIC) 5047 - Medical, Dental, and Hospital Equipment and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2019
MRQ
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 65112002
Cash and cash equivalents 65112002
Prepaid expense 27226476185694
Total current assets: 92237496186696
Noncurrent Assets
Intangible assets, net (including goodwill)    184
Intangible assets, net (excluding goodwill)    184 
Other undisclosed noncurrent assets     134
Total noncurrent assets:    184134
TOTAL ASSETS: 92237496370830
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 1,4531,10168510050
Taxes payable 9459   
Employee-related liabilities 216116   
Accounts payable 1,143926685399133
Other undisclosed accounts payable and accrued liabilities    (299)(83)
Debt 46810063296 
Due to related parties 350261231530288
Other undisclosed current liabilities 834289114346227
Total current liabilities: 3,1051,7511,0921,271565
Noncurrent Liabilities
Long-term debt and lease obligation 2,5712,7392,4481,4752,561
Long-term debt, excluding current maturities 2,5712,7392,4481,4752,561
Liabilities, other than long-term debt     144
Due to related parties     144
Other undisclosed noncurrent liabilities     (1,647)
Total noncurrent liabilities: 2,5712,7392,4481,4751,058
Total liabilities: 5,6754,4903,5412,7461,624
Equity
Equity, attributable to parent (5,584)(4,253)(3,045)(2,377)(794)
Common stock 98754
Additional paid in capital 26,85723,2708,4666,7135,357
Accumulated deficit (32,450)(27,531)(11,518)(9,094)(6,155)
Total equity: (5,584)(4,253)(3,045)(2,377)(794)
TOTAL LIABILITIES AND EQUITY: 92237496370830

Income Statement (P&L) ($ in thousands)

3/31/2019
TTM
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenues
(Revenue, Net)
 10010050  
Cost of revenue
(Cost of Goods and Services Sold)
   (8)(31) 
Gross profit: 10010042(31) 
Operating expenses (1,411)(2,034)(1,860)(2,127)(2,863)
Other undisclosed operating loss (3,608)(14,079)(605)(782)(505)
Operating loss: (4,919)(16,013)(2,424)(2,940)(3,369)
Nonoperating expense  (13,975)  (505)
Other nonoperating expense  (13,979)  (505)
Interest and debt expense (347)13,779(134)(201)(142)
Loss from continuing operations before equity method investments, income taxes: (5,266)(16,209)(2,557)(3,140)(4,016)
Other undisclosed income from continuing operations before income taxes 347 134201647
Loss from continuing operations: (4,919)(16,209)(2,424)(2,940)(3,369)
Loss before gain (loss) on sale of properties: (4,919)(16,209)(2,424)(2,940)(3,369)
Other undisclosed net income  196   
Net loss available to common stockholders, diluted: (4,919)(16,013)(2,424)(2,940)(3,369)

Comprehensive Income ($ in thousands)

3/31/2019
TTM
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net loss: (4,919)(16,013)(2,424)(2,940)(3,369)
Comprehensive loss, net of tax, attributable to parent: (4,919)(16,013)(2,424)(2,940)(3,369)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: